Article

Effectiveness of the MF59-adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta-analysis

2021-04-25

Abstract excerpt

<h4>Background: </h4> Standard dose seasonal influenza vaccines often produce modest immunogenic responses in adults ≥65 years old. MF59 is intended to elicit a greater magnitude and increased breadth of immune response. <h4>Objective:</h4> To determine the effectiveness of seasonal MF59-adjuvanted trivalent/quadrivalent influenza vaccine (aTIV/aQIV) relative to no vaccination or vaccination with standard or high...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c07f5f1b-4c5a-5720-b63f-f5d8dcd803a8
DOI: 10.22541/au.161933909.92394260/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effectiveness of the MF59-adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta-analysisDOI 10.22541/au.161933909.92394260/v1Read

A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and olderSemantic proximity Read

Vaccine effectiveness against influenza A(H3N2) and B among laboratory‐confirmed, hospitalised older adults, Europe, 2017‐18: A season of B lineage mismatched to the trivalent vaccineSemantic proximity Read

Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023–24 seasonSemantic proximity Read

Comparison of the Safety and Immunogenicity of a Novel Matrix-M-adjuvanted Nanoparticle Influenza Vaccine with a Quadrivalent Seasonal Influenza Vaccine in Older Adults: A Randomized Controlled TrialSemantic proximity Read

Influenza vaccine effectiveness in Europe: Results from the 2022–23 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre studySemantic proximity Read

Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza SeasonSemantic proximity Read

Estimation of the Effectiveness of Quadrivalent Influenza Vaccines by Distinguishing Between Influenza A (H1N1) pdm09 and Influenza A (H3N2) Using Rapid Influenza Diagnostic Tests During the 2018-2019 Season.Semantic proximity Read

Influenza activity - United States, 2014-15 season and composition of the 2015-16 influenza vaccine.Semantic proximity Read

Influenza vaccine-specific T cell responses are impaired in older adultsSemantic proximity Read

Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly ResidentsSemantic proximity Read

Quadrivalent adjuvanted haemagglutinin nanoparticle influenza vaccine: a step towards better protection of older adults from the constantly mutating H3N2 influenza viruses.Semantic proximity Read

Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in ChildrenSemantic proximity Read